Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF INDIA
10/13/2014 10/14/2014 10/16/2014 10/17/2014 10/20/2014 Date
2739.8(c) 2750(c) 2686.95(c) 2735.05(c) 2738(c) Last
8 371 10 578 8 639 6 487 5 344 Volume
+0.49% +0.37% -2.29% +1.79% +0.11% Change
More quotes
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
11/06Earnings Release
Surperformance© rating of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More about the company
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Financials ( INR)
Sales 2014 27 936 M
EBIT 2014 6 213 M
Net income 2014 5 302 M
Finance 2014 13 510 M
Yield 2014 2,06%
Sales 2015 30 645 M
EBIT 2015 7 279 M
Net income 2015 6 401 M
Finance 2015 9 287 M
Yield 2015 2,14%
PER 2014 43,11
PER 2015 35,78
EV / Sales 2014 7,71x
EV / Sales 2015 7,17x
Capitalization 228 889 M
More Financials
Latest news on GLAXOSMITHKLINE PHARMACEUT
3d ago GLAXOSMITHKLINE : PRESS: Glaxo's Ebola Drug To "Come Too Late" For Current Outbr..
3d ago GLAXOSMITHKLINE : Glaxo Gets Positive Results For Anoro Ellipta COPD Treatment
5d ago GLAXOSMITHKLINE PHARMACEUTICALS : Taurus Securities Limited Market Roundup
6d ago GLAXOSMITHKLINE : DIRECTOR DEALINGS: Glaxo Directors, Managers Reinvest Dividend..
10/08 GLAXOSMITHKLINE : PRESS: Glaxo Investigating Allegations In United Arab Emirates..
10/07 GLAXOSMITHKLINE : Glaxo's Stiefel Starts Phase III Study Of Subcutaneous Ofatumu..
10/01 Isis Pharma Earns USD1.5 Million From Glaxo For ISIS-GSK4 Rx
09/30 GLAXOSMITHKLINE : Glaxo Announces USD5M Fund For Bioelectronics Research
09/25 GLAXOSMITHKLINE : New role for RBS chairman
09/25 PRESS : Glaxo Poised To Appoint RBS' Hampton As Chairman - FT
09/20 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo fined ; companies today
09/20 GLAXOSMITHKLINE : BRIBERY FINE FOR DRUG FIRM ; BRITAIN Briefing
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF